
        <!DOCTYPE html>
        <html>
        <head>
            <title>Rocket Pharmaceuticals Inc. (RCKT) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Rocket Pharmaceuticals Inc. (RCKT)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">← Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">54</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">8</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">17</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">-0.08</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=77ff43293994667b637d21ccfb65cd363bf74e7c829b1f6863f091695f1635fc" target="_blank" rel="noopener noreferrer">August 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-08</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.44
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f95aedfb38ab802721ee21b30416866641a9eff9d67686b984f0819c095a097d" target="_blank" rel="noopener noreferrer">Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-08</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=77f8583fbb66e95673861eb1d391ca13b0b97fe12be1cdf23a8ef31c0de3b758" target="_blank" rel="noopener noreferrer">RCKT Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-08</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0bd267164150c56134222dbae14cce631e08d29676c3e13a6fa1307257505d5c" target="_blank" rel="noopener noreferrer">The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-07</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 7, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. . ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5c010c070c4a03ae3eaf814b2d7aace1251e3a6fbd388e6c13b613ddbc1d46f4" target="_blank" rel="noopener noreferrer">Investors in Rocket Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-07</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ef3941ba6b268aa669266bac03c3b0a84a350d436dae22c9d662e5ebddc95bb4" target="_blank" rel="noopener noreferrer">Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-07</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.69
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 7, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. . Such investors are advised to contact Danielle......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=daf8a338f21a2a5db7d14b38e19c8bc10fdb32f8308d8cec03465bcff8f402f9" target="_blank" rel="noopener noreferrer">RCKT Investors Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-07</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 7, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3b33eb52e97bd3dcc87dee190bdbbd0a36155fab9ac6be8eda164940c87f2261" target="_blank" rel="noopener noreferrer">SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-03</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their OptionsIf you purchased......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1b67c2331a97ceaffe812e3b7e0cabf8dd0b5cbf32afaaa529093958263ed1d0" target="_blank" rel="noopener noreferrer">Investors in Rocket Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before August 11, 2025 to Discuss Your Rights - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-03</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. . ......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=519c21c679869d59dc6c12ae11188b9521c9385132ecfe1de8000be1e3e3dfaa" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-03</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.29
                                </span>
                            </div>
                            <div class="article-summary">LOS ANGELES, July 3, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Rocket Pharmaceuticals, Inc. have opportunity to lead the securities fraud......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=496dce2a2a48c301bb637954e4bf3ecf5cf3dfdf5e26f922b94799796898057d" target="_blank" rel="noopener noreferrer">Shareholders That Lost Money on Rocket Pharmaceuticals, Inc. (RCKT) Should Contact Levi & Korsinsky About Pending Class Action - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-02</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5afa78dd949de966ff0108db88f2ec4fc84336c30449ad3e767451fdcea68bca" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals receives FDA clearance of RP-A701</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.37
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals (RCKT) announced that it has received clearance from the FDA for the company’s investigational new drug application for RP-A701, an AAVrh.74-based gene therapy candidate for the...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=de81c82cec2d7537ba8639fb5ec62c6869c8bbeebbe58fafa376eb5aa50dc06a" target="_blank" rel="noopener noreferrer">RCKT's IND for RP-A701 in Dilated Cardiomyopathy Gets FDA Clearance</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.86
                                </span>
                            </div>
                            <div class="article-summary">FDA clears Rocket Pharmaceuticals' IND for RP-A701, advancing its gene therapy for BAG3-linked dilated cardiomyopathy....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=40b6ba3224a48bd2c76884288affd9d673de0a7e621ad5daf63079ed99477c21" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc.(NasdaqGM: RCKT) added to Russell 3000E Value Index</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-30</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals, Inc. added to Russell 3000E Value Index......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0acbda07f4a27757fb076b0c1994d0084d4539fcb79ebb88a90f85993883ab56" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc.(NasdaqGM: RCKT) added to Russell 2000 Value Index</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-30</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.34
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals, Inc. added to Russell 2000 Value Index......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d43d161d6ff6645ba51e071f3b129f89f39349ee8b70f5a9cc9a7a866bc8d60c" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-30</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.76
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals, Inc. announced that it has received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug application for RP-A701, an AAVrh.74-based.....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=78adbbaeef54602d904fec7fdd6741d70df0dc0c76581d3e31cf98cde3f98988" target="_blank" rel="noopener noreferrer">The Gross Law Firm Reminds Rocket Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-30</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, June 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. . ......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=07e44c2f417515a4178956a47a17e6ca262fd5c8af1dadd55189a462aee7ebba" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc.(NasdaqGM: RCKT) added to Russell Small Cap Comp Value Index</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-30</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.79
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals, Inc. added to Russell Small Cap Comp Value Index......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f3d74a71fd2e4e1aa85ebe041f99258d63c6a47ed1ac12ca378c27d5654ee113" target="_blank" rel="noopener noreferrer">Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-30</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3d977765e4d5fddf844aee43e8f2c263b3813ba38eb6d775b5c364f5a166bbec" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">CRANBURY, N.J., June 30, 2025--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorder...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5bd4cf63a63b63fae0716d02549d4bfc83e9afe22c7b719a6ef250e58812abae" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc.(NasdaqGM: RCKT) added to Russell 2500 Value Index</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-30</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.32
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals, Inc. added to Russell 2500 Value Index......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=440b98e0cad4fe11e16c57e93219dac7be189ba7cc9f1e649f835524ef39df60" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc.(NasdaqGM: RCKT) added to Russell 3000 Value Index</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-30</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.30
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals, Inc. added to Russell 3000 Value Index......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f30dd60b3f72c3806243511e18e343bdaef870872854af7fffbc7068a7577dbb" target="_blank" rel="noopener noreferrer">Shareholders that lost money on Rocket Pharmaceuticals, Inc.(RCKT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.45
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, June 27, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=de6cef1fe1d27cd6e795ea87b8beb77a409b66b2d1ada6fc1d768481dab503ee" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4bbd1ca82e01a9e528e36a06fc4b06d62f326f2ec5c46bfef71e0542034063c3" target="_blank" rel="noopener noreferrer">Deadline Alert: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.32
                                </span>
                            </div>
                            <div class="article-summary">Glancy Prongay & Murray LLP reminds investors of the upcoming August 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=92b4624e4233c5118dceb086468ae460d022c5b3da48e193bafd6c0802a234c6" target="_blank" rel="noopener noreferrer">ROSEN, LEADING INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, June 27, 2025 /PRNewswire/ -- WHY: New York, N.Y., June 27, 2025. Rosen......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1adce79870b40ce677ad07a848992c37d2e94e7d4f136b9318643225073970ca" target="_blank" rel="noopener noreferrer">Shareholders that lost money on Rocket Pharmaceuticals, Inc.(RCKT) should contact The Gross Law Firm about pending Class Action - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-26</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, June 26, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. . ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6c325d3580329d15fe897b51fa5ee8ecb3ae0e74f12a94e9fd59b1ab49140ef0" target="_blank" rel="noopener noreferrer">Deadline Approaching: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-26</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Law Offices of Howard G. Smith reminds investors of the upcoming August 11, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Rocket Pharmaceuticals,...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=07f7cfd4b80e506c6490f7f3108330b67949b3da55e048e97b6b61b3ff576162" target="_blank" rel="noopener noreferrer">RCKT Investors Have the Opportunity to Lead the Rocket Pharmaceuticals Securities Fraud Lawsuit with Faruqi & Faruqi, LLP</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-26</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=482731d78bc14fd3fe9ad167289e7b7626186b0d99845c7d6554e8c2f4c5de8f" target="_blank" rel="noopener noreferrer">Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Rocket Pharmaceuticals, Inc. (RCKT) Shareholders</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-25</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=23fc9ee205ae37e1c398d56e8364ca94cd9ac8bd31b7ea3a3cce8bbfc4ea77b7" target="_blank" rel="noopener noreferrer">Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-24</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.45
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, June 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=796e644a516e3995f8a41ec9f5b136fa500d058f2d9eb6b706e4616c7be2eb80" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Rocket Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-24</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who.....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=faa8e41efd8bf6f3f7e89590fbca419b7b9bba523b700185e82e1e1ada9bae86" target="_blank" rel="noopener noreferrer">Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Rocket Pharmaceuticals, Inc. (RCKT) Investors To Inquire About Securities Fraud Class Action</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-24</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.56
                                </span>
                            </div>
                            <div class="article-summary">Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=008be5af1d3058dd729b4ae55223fcaa377bda90d63dbc24cf7c641b245f2817" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-23</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, June 23, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. . ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=17335c900497afdff47dfc83dd859a0660866ff5f4fe8f3b8c06fa539e2b5fa5" target="_blank" rel="noopener noreferrer">Law Offices of Howard G. Smith Encourages Rocket Pharmaceuticals, Inc. (RCKT) Investors To Inquire About Securities Fraud Class Action</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-23</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Rocket Pharmaceuticals, Inc. securities between February 27, 2025 and May 26,.....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e2ebdad21a22c5dcec0f442e98128ee3437c8f9516741d835461bba4fabf0d82" target="_blank" rel="noopener noreferrer">Law Offices of Frank R. Cruz Encourages Rocket Pharmaceuticals, Inc. (RCKT) Investors To Inquire About Securities Fraud Class Action</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-23</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Rocket Pharmaceuticals, Inc. securities between February 27, 2025 and May......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=52800ca6a1a7fdda60fe7497ae43857c4276788ce30d668b76855abab4cee64e" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc.(NasdaqGM: RCKT) dropped from S&P Biotechnology Select Industry Index</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-22</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.95
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals, Inc. dropped from S&P Biotechnology Select Industry Index......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=91b9619219c152cdbf5f15f01ef328766b513293aed1b2e440b8a639651dc6ce" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-20</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.44
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, June 20, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e94cda1629521094babc44445f878e0b307f4d84628bf2adf4c1ee170eb908cc" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-20</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">SAN DIEGO, June 20, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Rocket Pharmaceuticals, Inc. ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b0388b1a5bafba81020e7fc8af446de6f775b49a6639e37a0b72a41106c7fc1e" target="_blank" rel="noopener noreferrer">Faruqi & Faruqi Reminds Rocket Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-20</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their OptionsIf you purchased......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=65ea4fec272e74fb3ae61cb37220f0da56d3cdccf9e1a18b2852782bbbe0304a" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-20</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.24
                                </span>
                            </div>
                            <div class="article-summary">Law Offices of Howard G. Smith announces an investigation on behalf of Rocket Pharmaceuticals, Inc. investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3a520ee32850564ac65ef9f309a7aabd912fb594689166a1a80a01624c64cbd0" target="_blank" rel="noopener noreferrer">Securities Fraud Investigation Into Rocket Pharmaceuticals, Inc. (RCKT) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-20</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Rocket Pharmaceuticals, Inc. investors concerning the.....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4010113ed3005ff1bd12be9f245a836ee25b2d9a0cae0889c9409c6bd2043f9e" target="_blank" rel="noopener noreferrer">Gene Therapy Was the Biggest Idea in Biotech. Now It Has Lost Support on Wall Street.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.85
                                </span>
                            </div>
                            <div class="article-summary">Five years ago, scientists and investors were excited about gene therapy offering one-and-done cures for deadly diseases. Today, much of the enthusiasm has dried up....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=48b45b08ab5a92799ec137810a0b791cdd59719fa5de65f27794d2aad0fbb453" target="_blank" rel="noopener noreferrer">RCKT INVESTOR NOTICE: Robbins Geller Rudman & Dowd Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-19</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    -0.19
                                </span>
                            </div>
                            <div class="article-summary">The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. securities between February 27, 2025 and May 26, 2025, inclusive , have until......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=fc49b2b4a25a5650ecda16800c0f29ff3170d3d09f746cc45139d65470ca0e2e" target="_blank" rel="noopener noreferrer">Gene Therapy Has Lost Support on Wall Street. There’s Still Hope for Big Cures.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-19</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.81
                                </span>
                            </div>
                            <div class="article-summary">Five years ago, scientists and investors were excited about gene therapy offering one-and-done cures for deadly diseases. Today, much of the enthusiasm has dried up....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c822edcad0b07aa5099db447e881557767c2d06b491260a009520a197d98cb8b" target="_blank" rel="noopener noreferrer">Shareholders that lost money on Rocket Pharmaceuticals, Inc.(RCKT) Urged to Join Class Action - Contact The Gross Law Firm to Learn More</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-19</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, June 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. . ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=422cfde67c4b87fe5d5de9cebdb2d96c27901b76eb2314e20acacd2fe6a3994f" target="_blank" rel="noopener noreferrer">Securities Fraud Investigation Into Rocket Pharmaceuticals, Inc. (RCKT) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-18</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The Law Offices of Frank R. Cruz announces an investigation of Rocket Pharmaceuticals, Inc. on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=657425d52acf19b5c24f2416a1462ac3a394e5128ebe755f645b7e7e5d5d9463" target="_blank" rel="noopener noreferrer">Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-17</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, June 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. . Such investors are advised to contact Danielle Peyton at......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3e04f465e74cda860feb2f489631cefa672ca85ba7522df1ec38ba558dca8154" target="_blank" rel="noopener noreferrer">RCKT Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-16</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.66
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, June 16, 2025 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=baa536c8d2928ae9681288c28841a45a5657b866a24ba6890537f1fad5973167" target="_blank" rel="noopener noreferrer">INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-15</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4d436ad9eb661fac87a345a94a84768343773c52cf97fe566bf8dbe7988fba2c" target="_blank" rel="noopener noreferrer">RCKT Robbins Geller Rudman & Dowd Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-14</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.23
                                </span>
                            </div>
                            <div class="article-summary">The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. securities between February 27, 2025 and May 26, 2025, both dates inclusive ,......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a872ec2d35211c5d1f747167ff02a19251ad6f287e7e4df433b0572c85247d18" target="_blank" rel="noopener noreferrer">Contact Levi & Korsinsky by August 11, 2025 Deadline to Join Class Action Against Rocket Pharmaceuticals, Inc.(RCKT)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-13</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.45
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, June 13, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. of a class action securities lawsuit. ......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e65ea27194f926f456be67cb84fdb35c8c726111d82f28e2b59eb95b8430cd65" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial - Hagens Berman</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-13</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.38
                                </span>
                            </div>
                            <div class="article-summary">RCKT Investors with Losses Encouraged to Contact the FirmSAN FRANCISCO, June 13, 2025 /PRNewswire/ -- A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No.......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d9cbe414064a0f21de39b6861ac61d8e5826efe3ac2ad5c6989cbb6fbcfa43e8" target="_blank" rel="noopener noreferrer">Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-12</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.39
                                </span>
                            </div>
                            <div class="article-summary">Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Rocket Pharmaceuticals, Inc. securities between......</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        